A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.
Status:
Withdrawn
Trial end date:
2021-10-12
Target enrollment:
Participant gender:
Summary
A 6-week double-blind study to evaluate the safety and efficacy of Quillichew extended
release chewable tablets in 4-5 year old children with attention deficit hyperactivity
disorder.